EXELIXIS, INC.

For the period ended Oct 2, 2026. Filed Oct 29, 2026.

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Oct 2, 2026 · Filed Oct 29, 2026

EXEL$70.58-1.6%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Condensed Consolidated Statements of Income (Unaudited)

CONDENSED CONSOLIDATED STATEMENTS OF INCOME

(in thousands, except per share data)

	Three Months Ended September 30,		Nine Months Ended September 30,
	2026	2025	2026	2025
Revenues:
Net product revenues	$604,924	$542,930	$1,732,926	$1,576,227
Collaboration revenues	53,772	54,825	165,272	145,236
Total revenues	658,696	597,755	1,898,198	1,721,463
Operating expenses:
Cost of goods sold	26,233	18,574	66,843	57,216
Research and development	209,481	199,164	621,384	611,753
Selling, general and administrative	154,559	123,661	441,793	395,703
Restructuring	—	19,816	—	19,816
Total operating expenses	390,273	361,215	1,130,020	1,084,488
Income from operations	268,423	236,540	768,178	636,975
Interest income	14,315	15,922	44,652	51,787
Other income (expenses), net	47	(49)	320	(244)
Income before income taxes	282,785	252,413	813,150	688,518
Provision for income taxes	64,690	58,835	172,538	150,476
Net income	$218,095	$193,578	$640,612	$538,042
Net income per share:
Basic	$0.88	$0.72	$2.54	$1.97
Diluted	$0.85	$0.69	$2.46	$1.90
Weighted-average common shares outstanding:
Basic	246,756	268,421	251,964	273,269
Diluted	255,754	278,535	260,917	283,701

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.